hematopoiet
stem
cell
transplant
hsct
defin
transplant
hematopoiet
stem
cell
origin
bone
marrow
cord
peripher
blood
donor
recipi
case
allogen
transplant
patient
case
autolog
stem
cell
harvest
vitro
return
individu
part
transplant
procedur
goal
hsct
achiev
engraft
administ
cell
thu
result
recipi
lymphohematopoiet
system
deriv
hct
graft
ultim
goal
mani
hct
protocol
achiev
optim
graftversustumor
gvt
activ
patient
malign
time
first
hematopoiet
stem
cell
transplant
report
jm
goldman
late
bone
marrow
transplant
use
treatment
choic
allogen
transplant
shown
improv
outcom
wide
array
disord
includ
leukemia
lymphoma
myelodysplast
syndrom
md
myeloprolif
disord
congenit
immunodefici
enzym
defici
bone
marrow
bm
failur
syndrom
howev
signific
morbid
mortal
associ
allogen
hct
due
regimenrel
toxic
rrt
graft
versu
host
diseas
gvhd
recommend
regard
transplant
individu
patient
requir
care
risk
assess
take
account
diseas
comorbid
previou
therapi
standard
therapi
avail
underli
donor
stem
cell
histoincompat
must
care
recent
updat
regul
made
donor
screen
infecti
diseas
stringent
order
avoid
chanc
unsuspect
patient
get
infect
idea
screen
paramet
make
stem
cell
product
safe
recent
introduct
nucleic
acid
test
nat
even
brought
window
period
less
day
princ
sultan
militari
medic
citi
psmmc
effort
made
screen
donor
infecti
diseas
recent
nat
test
becom
mandatori
american
associ
blood
bank
aabb
know
earlier
sampl
screen
serolog
paramet
infecti
diseas
screen
done
per
aabb
standard
infecti
diseas
screen
also
necessit
us
fda
per
standard
cfr
sampl
pend
infecti
diseas
screen
result
quarantin
thu
minim
chanc
cross
contamin
elig
donor
studi
highlight
prevent
strategi
due
infecti
diseas
screen
among
hsct
donor
period
recommend
guidelin
cdc
infecti
diseas
societi
america
american
societi
blood
marrow
transplant
american
associ
blood
bank
aabb
aim
highlight
effect
diseas
screen
elimin
preval
hiv
hepat
b
c
cmv
infect
syphili
case
among
hsct
donor
questionnair
conform
requir
food
drug
administr
fda
american
associ
blood
bank
aabb
foundat
accredit
cellular
therapi
fact
questionnair
written
dual
languag
name
english
arab
donor
illiter
assist
given
donor
fill
questionnair
donor
must
ask
fill
accur
correct
inform
especi
medic
histori
section
medic
histori
prospect
hsct
donor
contain
inform
histori
vaccin
week
period
prior
donat
travel
histori
includ
travel
certain
countri
list
countri
promin
endem
diseas
might
transmit
hsct
eg
malaria
chaga
diseas
viral
hepat
leishmaniasi
mu
also
detrmin
donor
ever
defer
plasma
blood
donat
type
deferr
must
ascertain
histori
blood
product
transfus
solid
organ
transplant
previou
month
need
determin
histori
risk
factor
classic
creutzfeltjacob
diseas
medic
histori
indic
donor
clinic
evid
risk
acquir
bloodborn
infect
eg
htlv
ii
hepat
b
hepat
c
signific
incid
malaria
saudi
arabia
includ
screen
malaria
part
questionnair
ascertain
donor
visit
malaria
infect
area
necessari
screen
malaria
perform
screen
undertaken
prior
hematopoiet
stem
cell
collect
prospect
donor
screen
carri
donor
allogen
patient
autolog
part
bone
marrow
transplant
bmt
workup
procedur
hiv
hepat
cmvigm
screen
perform
enzym
link
immunosorb
assay
elisa
syphili
screen
perform
vener
diseas
research
laboratori
vdrl
test
confirm
treponema
pallidum
haemagglutin
assay
addit
adher
standard
screen
obtain
medic
histori
stem
cell
donor
subject
bone
marrow
transplant
workup
ensur
donor
good
health
prior
stem
cell
donat
complet
screen
donor
clear
infecti
diseas
allow
donat
hematopoiet
stem
cell
peripher
blood
stem
cell
collect
prospect
donor
standard
apheresi
procedur
total
number
donorspati
recruit
stem
cell
transplant
complet
infecti
diseas
screen
donorspati
carri
studi
approv
department
research
ethic
committe
analyz
total
patient
donat
stem
cell
either
autolog
allogen
usag
male
femal
ratio
approxim
equal
number
autolog
allogen
hematopoiet
stem
cell
collect
undertaken
median
age
autolog
donor
year
wherea
allogen
donor
year
infecti
diseas
patient
enumer
shown
tabl
transplant
carri
broadli
classifi
two
major
group
autolog
allogen
transplant
two
major
group
sub
classifi
basi
sex
variou
age
group
donor
enumer
chart
tabul
distribut
male
femal
donor
among
variou
age
group
autolog
allogen
donor
shown
tabl
infecti
diseas
screen
done
donor
irrespect
natur
transplant
seen
preval
infecti
diseas
donorspati
identifi
transplant
seen
chart
stem
cell
donor
found
patient
autolog
condit
donor
allogen
infect
isol
transplant
regim
hematopoiet
stem
cell
publish
us
recent
journal
devis
new
novel
strategi
isol
stem
cell
suitabl
donor
enumer
number
stem
cell
isol
collect
correl
number
cd
cell
enumer
peripher
blood
final
number
stem
cell
isol
per
kg
bodi
weight
patient
collect
minimum
cd
cell
donorpati
per
kg
bodi
weight
collect
perform
cd
level
reach
minimum
multipl
collect
gener
perform
singl
donor
till
minimum
amount
attain
cryopreserv
stem
cell
transplant
post
chemotherapi
strict
regim
infecti
diseas
screen
allogen
donor
donor
maintain
found
free
hiv
hepat
syphili
cytomegaloviru
cmv
prior
accept
potenti
donor
autolog
patient
also
screen
infecti
diseas
segreg
infect
sampl
rest
cryopreserv
tank
infecti
diseas
test
hiv
hepat
b
c
done
analyz
antibodi
titer
elisa
method
later
advanc
analysi
led
advanc
method
detect
nucleic
acid
test
nat
hiv
hepat
screen
thu
bring
window
period
detect
day
becam
part
aabb
guidelin
coupl
year
ago
earlier
guidelin
hiv
hepat
test
done
elisa
becam
mandatori
per
fda
aabb
guidelin
donor
must
screen
nat
test
addit
serolog
test
nat
test
mandatori
hiv
hcv
becam
import
detect
small
quantiti
rna
elig
donor
allogen
donat
search
within
famili
suitabl
hla
match
patient
stage
everi
donor
patient
screen
hospit
part
bmt
workup
infecti
diseas
screen
done
per
aabb
standard
involv
infecti
diseas
screen
test
done
hiv
hbsag
hbc
hcv
syphili
till
date
peripher
blood
stem
cell
unit
harvest
donorspati
almost
equal
number
autolog
allogen
unit
collect
around
allogen
donor
analyz
data
infecti
diseas
screen
ascertain
unit
store
donor
test
posit
infecti
diseas
screen
analyz
infect
donor
infecti
diseas
hiv
hepat
cmvigm
syphili
find
donor
infect
hiv
per
nat
test
protocol
next
test
number
donor
show
posit
result
hepat
b
surfac
antigen
hbsag
per
fact
aabb
guidelin
donor
seroposit
hbsag
perman
defer
donat
autolog
donor
found
posit
hbsag
autolog
donor
accept
provid
stem
cell
unit
segreg
test
sampl
analyz
common
antibodi
detect
hepat
hbc
hepat
b
core
antibodi
antibodi
result
onset
symptom
acut
hepat
b
persist
life
antihbc
indic
previou
ongo
infect
hepat
b
viru
observ
donor
hbc
antibodi
posit
neg
hbsag
hepat
test
done
nat
assay
also
indic
patient
current
hepat
incid
indic
either
infect
resolv
fals
posit
result
hepat
b
data
antihb
hepat
b
surfac
antibodi
order
indic
whether
presenc
hbc
antibodi
due
recent
vaccin
next
analyz
preval
hepat
c
antibodi
donor
recruit
stem
cell
transplant
singl
autolog
case
posit
indic
hepat
c
viru
confirm
nat
test
protocol
found
autolog
case
cmvigm
hepat
c
cmvigm
sampl
also
quarantin
stem
cell
store
use
autolog
administr
age
common
stem
cell
donat
year
among
donor
median
age
autolog
donor
year
median
age
allogen
donor
year
case
autolog
util
stem
cell
includ
patient
suffer
lymphoma
multipl
myeloma
allogen
usag
stem
cell
involv
donor
close
rel
sibl
probabl
good
hla
match
patient
includ
leukemia
necessit
stem
cell
transplant
hla
match
donor
donorpati
match
maintain
elimin
possibl
gvhd
stem
cell
transplant
shown
chart
case
infecti
diseas
report
donorsrecipi
analysi
tabl
show
case
allogenen
donor
show
seroposit
result
infecti
diseas
screen
case
indic
posit
result
hbcab
hepat
b
core
antibodi
confirm
test
hbsag
hepat
b
surfac
antigen
hepat
bnat
test
show
neg
result
indic
previou
incid
hepat
b
current
preval
donor
moment
yet
perform
test
hepat
b
surfac
antibodi
antihb
perform
test
antihepat
b
e
antibodi
antihb
report
nation
averag
hiv
case
saudi
arabia
case
per
subject
high
preval
hepat
case
saudi
arabia
around
new
case
detect
everi
year
hepat
b
viru
form
major
case
follow
hepat
c
viru
howev
syphili
case
amount
popul
saudi
arabia
per
regul
aabb
stem
cell
donor
clear
seroneg
hiv
hepat
c
clear
mandatori
nucleic
acid
test
nat
nat
test
hepat
b
dna
discontinu
decemb
nevertheless
conduct
hiv
well
hepat
test
elisa
well
nucleic
acid
test
nat
import
potenti
donor
screen
evalu
gener
state
health
whether
pose
risk
transmiss
infecti
diseas
recipi
evalu
donor
achiev
screen
laboratori
test
describ
disord
pertain
hct
categor
accord
preval
sever
differ
area
differ
assess
criteria
nation
law
particular
countri
take
preced
intern
law
thu
concern
pertain
likelihood
disord
within
potenti
donor
popul
highli
depend
upon
donor
geograph
locat
sever
relat
consequ
disord
eas
manag
consequ
includ
pathogen
condit
highli
pertin
includ
hiv
hepat
b
viru
hbv
hepat
c
viru
hcv
human
tcell
leukemia
virus
type
ii
htlvi
htlvii
west
nile
donor
screen
regim
includ
physic
examin
donor
histori
previou
donat
review
medic
record
screen
must
done
preced
donat
ml
donor
plasma
store
stem
cell
collect
due
possibl
develop
new
risk
assess
critic
aspect
discoveri
new
risk
find
necessit
potenti
donor
might
requir
evalu
potenti
donor
first
undergo
hla
match
analysi
hla
match
done
sibl
donor
find
perfect
match
perfect
match
allow
donat
part
direct
donat
regim
select
donor
medic
histori
compil
includ
complet
bmt
work
infecti
diseas
screen
complet
hematolog
analysi
blood
group
analysi
biochemistri
analysi
microbiolog
analysi
x
ray
investig
physic
examin
donor
also
undertaken
aim
detect
stigmata
associ
transfus
transmiss
diseas
donor
undergon
requir
test
signific
find
defer
stem
cell
donat
allow
donat
document
donor
select
complet
incid
low
almost
neglig
preval
infecti
diseas
due
stringent
criteria
adopt
prior
collect
stem
cell
sampl
howev
perform
infecti
diseas
screen
patient
post
transplant
import
current
standard
prevent
extrins
bacteri
fungal
contamin
follow
personnel
involv
collect
transport
process
storag
final
transplant
requir
follow
strict
protocol
avoid
accident
contamin
stem
cell
product
note
earlier
cryogen
temperatur
harvest
hepat
b
virusinfect
peripher
blood
progenitor
cell
product
thu
imper
ensur
absolut
hematopoiet
stem
cell
graft
safeti
success
transplant
outcom
transport
servic
involv
long
distanc
transport
need
follow
iata
guidelin
detail
food
drug
administr
fda
good
tissu
practic
regul
european
fact
netcord
standard
cord
blood
collect
process
test
bank
select
regul
updat
ensur
risk
free
transplant
patient
constant
endeavor
improv
qualiti
stem
cell
product
safe
transplant
addit
effect
transplant
graft
human
lymphocyt
viru
htlv
includ
infecti
diseas
screen
paramet
aabb
also
recent
includ
paramet
part
infecti
diseas
screen
regim
local
intern
regul
might
request
particular
test
depend
sever
intens
diseas
defin
world
health
organ
sever
intens
diseas
may
local
particular
region
may
countri
specif
recent
discov
coronaviru
primarili
infect
upper
respiratori
gastrointestin
tract
caus
sever
acut
respiratori
syndrom
sar
detect
mani
part
world
confirm
preval
diseas
middl
east
signific
number
death
take
place
due
sar
thu
introduc
screen
paramet
coronaviru
futur
prospect
donor
screen
one
critic
paramet
stem
cell
transplant
regul
standard
stress
donor
screen
order
provid
safe
transplant
negat
risk
accident
infect
recepi
blood
bank
stringent
criteria
donat
similarli
stem
cell
bank
taken
cue
blood
bank
direct
provid
safe
transplant
product
patient
facil
bmt
workup
includ
infecti
diseas
screen
done
day
prior
collect
stem
cell
unit
perform
nat
test
hiv
hcv
hbv
donor
sampl
retest
donor
sampl
requir
sampl
pbsc
store
transient
transplant
back
patient
thu
imper
perform
serolog
well
nat
test
initi
sampl
stem
cell
collect
